Physician

Channing Dale Willoughby, MD

According to 2025 Medicare claims, Channing Willoughby, MD (NPI: 1235336421) practices pain management in the Spartanburg, SC market, with the plurality of this provider's patient population coming from Spartanburg, SC. This provider's primary affiliated billing organization is CAROLINA ORTHOPAEDIC AND NEUROSURGICAL ASSOCIATES (NPI: 1568454056; TIN: 570510670) and primary practice location at 29303-4209.

Willoughby's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 952 traditional Medicare patients, billed 56,628 HCPCS/CPT codes, and received $767,074 in Medicare payments. The top billing code was G0480 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 7,634 prescription claims across 1,229 beneficiaries totaling $191,827 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). DME data shows 68 claims. Open Payments data shows 114 records totaling $22,428. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $251,541 to $767,074. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $119,933 and ending at $191,827. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$384K$767K2015 Medicare payment: $251,541 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $227,770 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $355,975 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $336,796 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $340,213 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $348,176 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $233,709 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $444,525 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $708,184 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $767,074 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153824,201$251,541
20163873,736$227,770
20175805,267$355,975
20185845,096$336,796
20195255,093$340,213
20205855,291$348,176
20215243,055$233,709
20221,0409,887$444,525
20231,08118,084$708,184
202495256,628$767,074

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$201K$402K2015 Drug cost: $119,933 (USD; Tot_Drug_Cst)2016 Drug cost: $401,935 (USD; Tot_Drug_Cst)2017 Drug cost: $245,300 (USD; Tot_Drug_Cst)2018 Drug cost: $223,731 (USD; Tot_Drug_Cst)2019 Drug cost: $234,529 (USD; Tot_Drug_Cst)2020 Drug cost: $203,540 (USD; Tot_Drug_Cst)2021 Drug cost: $108,245 (USD; Tot_Drug_Cst)2022 Drug cost: $101,963 (USD; Tot_Drug_Cst)2023 Drug cost: $193,410 (USD; Tot_Drug_Cst)2024 Drug cost: $191,827 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152561,762$119,933
20162782,510$401,935
20173903,049$245,300
20183462,892$223,731
20193633,124$234,529
20203573,090$203,540
20213571,725$108,245
20227252,325$101,963
20231,0866,242$193,410
20241,2297,634$191,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$25K$51K2022 Medicare payment: $38,032 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $42,671 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $50,887 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20224367$38,032
20235050$42,671
20246868$50,887

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0480Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms327570$109
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6011,655$82
80307Testing for presence of drug, by chemistry analyzers329581$58
Q9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml461869$0
J1010Injection, methylprednisolone acetate, 1 mg34339,760$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,49444,080$36,375
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,04530,832$31,880
RelistorMethylnaltrexone Bromide12255$19,829
GabapentinGabapentin1,14944,533$14,802
BuprenorphineBuprenorphine35980$8,325

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L0650Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelfN6868$50,887

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.114$22,428Nalu Medical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Channing Dale Willoughby, MD?

Tedicare shows public-source Medicare data for Channing Dale Willoughby, MD (NPI 1235336421), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Channing Dale Willoughby, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Channing Dale Willoughby, MD?

Channing Dale Willoughby, MD is linked to CAROLINA ORTHOPAEDIC AND NEUROSURGICAL ASSOCIATES (billing NPI 1568454056) in the available physician profile data.

Does Channing Dale Willoughby, MD have Open Payments data?

Channing Dale Willoughby, MD has 114 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.